COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in three investor conferences in September as follows:

• Citi 16th Annual BioPharma Virtual Conference: “Psychedelic Medicines for Mental Health Conditions” panel on 8th September at 2:20pm ET
• Morgan Stanley 19th Annual Global Healthcare Conference: virtual fireside chat on 9th September at 10:15am ET
• HC Wainwright 23rd Annual Global Investment Conference: on demand fireside chat available from 13 to 15 September

Members of the COMPASS management team will be holding investor meetings at the conferences.

Audio webcasts of the panel at the Citi conference and presentations at the Morgan Stanley and HC Wainwright conferences will be available on the “Events” page of the Investors section of the COMPASS website. A replay of the webcast will be available for 30 days following the event. For more information, please visit www.ir.compasspathways.com.

About COMPASS Pathways

COMPASS Pathways plc (Nasdaq: CMPS) is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we are currently conducting a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. We are headquartered in London, UK, with offices in New York, US. Our vision is a world of mental wellbeing. www.compasspathways.com     

Availability of other information about COMPASS Pathways

Investors and others should note that we communicate with our investors and the public using our website (www.compasspathways.com), our investor relations website (ir.compasspathways.com), and on social media (LinkedIn), including but not limited to investor presentations and investor fact sheets, US Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that we post on these channels and websites could be deemed to be material information. As a result, we encourage investors, the media, and others interested in us to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on our investor relations website and may include additional social media channels. The contents of our website or these channels, or any other website that may be accessed from our website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.  

Enquiries

Media: Tracy Cheung, This email address is being protected from spambots. You need JavaScript enabled to view it., +44 7966 309024
Investors: Stephen Schultz, This email address is being protected from spambots. You need JavaScript enabled to view it., +1 401 290 7423